These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 30819593)
1. P300 as an index of transition to psychosis and of remission: Data from a clinical high risk for psychosis study and review of literature. Tang Y; Wang J; Zhang T; Xu L; Qian Z; Cui H; Tang X; Li H; Whitfield-Gabrieli S; Shenton ME; Seidman LJ; McCarley RW; Keshavan MS; Stone WS; Wang J; Niznikiewicz MA Schizophr Res; 2020 Dec; 226():74-83. PubMed ID: 30819593 [TBL] [Abstract][Full Text] [Related]
2. Auditory N100 amplitude deficits predict conversion to psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) cohort. Duncan E; Roach BJ; Massa N; Hamilton HK; Bachman PM; Belger A; Carrion RE; Johannesen JK; Light GA; Niznikiewicz MA; Addington JM; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang M; Walker EF; Woods SW; Nasiri N; Mathalon DH Schizophr Res; 2022 Oct; 248():89-97. PubMed ID: 35994912 [TBL] [Abstract][Full Text] [Related]
3. Longitudinal evaluation of visual P300 amplitude in clinical high-risk subjects: An event-related potential study. Oribe N; Hirano Y; Del Re E; Mesholam-Gately RI; Woodberry KA; Ueno T; Kanba S; Onitsuka T; Shenton ME; Spencer KM; Niznikiewicz MA Psychiatry Clin Neurosci; 2020 Oct; 74(10):527-534. PubMed ID: 32519778 [TBL] [Abstract][Full Text] [Related]
5. Baseline Cortical Thickness Reductions in Clinical High Risk for Psychosis: Brain Regions Associated with Conversion to Psychosis Versus Non-Conversion as Assessed at One-Year Follow-Up in the Shanghai-At-Risk-for-Psychosis (SHARP) Study. Del Re EC; Stone WS; Bouix S; Seitz J; Zeng V; Guliano A; Somes N; Zhang T; Reid B; Lyall A; Lyons M; Li H; Whitfield-Gabrieli S; Keshavan M; Seidman LJ; McCarley RW; Wang J; Tang Y; Shenton ME; Niznikiewicz MA Schizophr Bull; 2021 Mar; 47(2):562-574. PubMed ID: 32926141 [TBL] [Abstract][Full Text] [Related]
6. Auditory and Visual Oddball Stimulus Processing Deficits in Schizophrenia and the Psychosis Risk Syndrome: Forecasting Psychosis Risk With P300. Hamilton HK; Woods SW; Roach BJ; Llerena K; McGlashan TH; Srihari VH; Ford JM; Mathalon DH Schizophr Bull; 2019 Sep; 45(5):1068-1080. PubMed ID: 30753731 [TBL] [Abstract][Full Text] [Related]
7. Temporal and time-frequency features of auditory oddball response in distinct subtypes of patients at clinical high risk for psychosis. Wu G; Tang X; Gan R; Zeng J; Hu Y; Xu L; Wei Y; Tang Y; Chen T; Li C; Wang J; Zhang T Eur Arch Psychiatry Clin Neurosci; 2022 Apr; 272(3):449-459. PubMed ID: 34333669 [TBL] [Abstract][Full Text] [Related]
8. Forecasting Remission From the Psychosis Risk Syndrome With Mismatch Negativity and P300: Potentials and Pitfalls. Hamilton HK; Roach BJ; Mathalon DH Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Feb; 6(2):178-187. PubMed ID: 33431345 [TBL] [Abstract][Full Text] [Related]
9. Abnormally Large Baseline P300 Amplitude Is Associated With Conversion to Psychosis in Clinical High Risk Individuals With a History of Autism: A Pilot Study. Foss-Feig JH; Guillory SB; Roach BJ; Velthorst E; Hamilton H; Bachman P; Belger A; Carrion R; Duncan E; Johannesen J; Light GA; Niznikiewicz M; Addington JM; Cadenhead KS; Cannon TD; Cornblatt B; McGlashan T; Perkins D; Seidman LJ; Stone WS; Tsuang M; Walker EF; Woods S; Bearden CE; Mathalon DH Front Psychiatry; 2021; 12():591127. PubMed ID: 33633603 [TBL] [Abstract][Full Text] [Related]
10. Auditory P300 as a predictor of short-term prognosis in subjects at clinical high risk for psychosis. Kim M; Lee TY; Lee S; Kim SN; Kwon JS Schizophr Res; 2015 Jul; 165(2-3):138-44. PubMed ID: 25956629 [TBL] [Abstract][Full Text] [Related]
11. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion. Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022 [TBL] [Abstract][Full Text] [Related]
12. P300 amplitude attenuation in high risk and early onset psychosis youth. Graber K; Bosquet Enlow M; Duffy FH; D'Angelo E; Sideridis G; Hyde DE; Morelli N; Tembulkar S; Gonzalez-Heydrich J Schizophr Res; 2019 Aug; 210():228-238. PubMed ID: 30685392 [TBL] [Abstract][Full Text] [Related]
13. Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort. Cullen AE; Addington J; Bearden CE; Stone WS; Seidman LJ; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Woods SW; Walker EF Psychoneuroendocrinology; 2020 May; 115():104649. PubMed ID: 32197198 [TBL] [Abstract][Full Text] [Related]
14. Cognitive dysfunction in a psychotropic medication-naïve, clinical high-risk sample from the ShangHai-At-Risk-for-Psychosis (SHARP) study: Associations with clinical outcomes. Cui H; Giuliano AJ; Zhang T; Xu L; Wei Y; Tang Y; Qian Z; Stone LM; Li H; Whitfield-Gabrieli S; Niznikiewicz M; Keshavan MS; Shenton ME; Wang J; Stone WS Schizophr Res; 2020 Dec; 226():138-146. PubMed ID: 32694037 [TBL] [Abstract][Full Text] [Related]
15. Eye movement indices as predictors of conversion to psychosis in individuals at clinical high risk. Zhang D; Xu L; Xie Y; Tang X; Hu Y; Liu X; Wu G; Qian Z; Tang Y; Liu Z; Chen T; Liu H; Zhang T; Wang J Eur Arch Psychiatry Clin Neurosci; 2023 Apr; 273(3):553-563. PubMed ID: 35857090 [TBL] [Abstract][Full Text] [Related]
16. Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a meta-analysis. De Herdt A; Wampers M; Vancampfort D; De Hert M; Vanhees L; Demunter H; Van Bouwel L; Brunner E; Probst M Schizophr Res; 2013 Sep; 149(1-3):48-55. PubMed ID: 23830855 [TBL] [Abstract][Full Text] [Related]
17. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium. Alderman T; Addington J; Bearden C; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cadenhead KS Early Interv Psychiatry; 2015 Dec; 9(6):467-75. PubMed ID: 24576057 [TBL] [Abstract][Full Text] [Related]
18. Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome. Modinos G; Allen P; Zugman A; Dima D; Azis M; Samson C; Bonoldi I; Quinn B; Gifford GWG; Smart SE; Antoniades M; Bossong MG; Broome MR; Perez J; Howes OD; Stone JM; Grace AA; McGuire P Schizophr Bull; 2020 Apr; 46(3):670-679. PubMed ID: 32227226 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis. Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573 [TBL] [Abstract][Full Text] [Related]
20. Predicting Remission in Subjects at Clinical High Risk for Psychosis Using Mismatch Negativity. Kim M; Lee TH; Yoon YB; Lee TY; Kwon JS Schizophr Bull; 2018 Apr; 44(3):575-583. PubMed ID: 29036493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]